Skip to main content

Day: February 19, 2025

Gevo to Report Fourth Quarter 2024 Financial Results on March 6, 2025

ENGLEWOOD, Colo., Feb. 19, 2025 (GLOBE NEWSWIRE) — Gevo, Inc. (NASDAQ: GEVO) announced today that it will host a conference call on March 6, 2025, at 4:30 p.m. ET (2:30 p.m. MT) to report its financial results for the fourth quarter ended December 31, 2024. To participate in the live call, please register through the following event weblink:https://register.vevent.com/register/BIfe02700a31384d12946e60bf35964cb8 After registering, participants will be provided with a dial-in number and pin. To listen to the conference call (audio only), please register through the following event weblink: https://edge.media-server.com/mmc/p/h9wkbjf5 A webcast replay will be available two hours after the conference call ends on March 6, 2025. The archived webcast will be available in the Investor Relations section of Gevo’s website at www.gevo.com. About...

Continue reading

DT Cloud Acquisition Corporation Announces Change of Extraordinary General Meeting Date

New York, New York, Feb. 19, 2025 (GLOBE NEWSWIRE) — DT Cloud Acquisition Corporation (Nasdaq: DYCQU, DYCQ, DYCQR) (“DT Cloud” or the “SPAC”), a publicly-traded special purpose acquisition company, today announced that its Extraordinary General Meeting (“EGM”), previously scheduled at 10:00 a.m. Eastern Time on February 18, 2025, has been postponed to 10:00 a.m. Eastern Time on February 21, 2025, and the redemption right deadline has been postponed to 5:00 p.m. Eastern Time on February 19, 2025. The Company filed a proxy supplement on February 14, 2025, as further amended on February 19, 2025, to increase the amended monthly extension fee, as proposed in the Proposal 1 to the EGM, to $0.022 for each outstanding Public Share. The proxy materials can be accessed on the SEC’s website at http://www.sec.gov. About DT Cloud Acquisition...

Continue reading

Better Choice Company Signs Definitive Agreement to Sell Halo Asia for $8.1 Million in Total Gross Proceeds

Upon closing, Better Choice will retain ownership of North American and rest-of-world ex-Asia operations TAMPA, Fla., Feb. 19, 2025 (GLOBE NEWSWIRE) — Better Choice Company, Inc. (NYSE American: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, is pleased to announce it has signed a definitive agreement with its existing partner in Asia, CZC Company LTD (the “Buyer”), to sell its Halo business in Asia for total gross proceeds of $8.1 million including $6.5 million in cash at closing, along with a 3% royalty on sales over the next five years, guaranteed by a minimum royalty payment of $330,000 per year or $1.65 million in total. Pursuant to the terms of the transaction, Better Choice will retain ownership of its North American and rest-of-world ex-Asia operations. Both parties expect to close the sale...

Continue reading

Serve Robotics Expands to Miami Metro, Offering Autonomous Delivery for Shake Shack and Mister O1

Serve Robotics Expands to Miami MetroServe Robotics announces the launch of its service in the Miami metro area, alongside the expansion of its existing partnership with Shake Shack Inc. and new partnership with Mister O1 Extraordinary Pizza.Autonomous robot deliveries rolling out in Miami Beach and Brickell via Uber Eats Select Shake Shack and Mister O1 customers may receive their next order from a Serve robot SAN FRANCISCO, Feb. 19, 2025 (GLOBE NEWSWIRE) — Serve Robotics Inc. (Nasdaq: SERV), a leading autonomous sidewalk delivery company, today announced the launch of its service in the Miami metro area, alongside the expansion of its existing partnership with Shake Shack Inc. (“Shake Shack”) (NYSE:SHAK) and new partnership with Mister O1 Extraordinary Pizza (“Mister O1”). Customers who order from select Shake Shack...

Continue reading

Revival Gold Announces Strategic Placement with Dundee Corporation

TORONTO, Feb. 19, 2025 (GLOBE NEWSWIRE) — Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to announce that it has entered into a non-brokered agreement with Dundee Corporation (TSX: DC.A) through its wholly owned subsidiary, Dundee Resources Limited (“Dundee”), pursuant to which Dundee has agreed to purchase 10,000,000 units of the Company (the “Units”) at a price of CAD$0.32 per Unit, for gross proceeds of CAD$3,200,000 (the “Placement”). Each Unit will consist of one common share of the Company (a “Common Share”) and one-half of one common share purchase warrant (each whole warrant, a “Warrant”). Each Warrant will entitle the holder thereof to acquire one Common Share of the Company at an exercise price of CAD$0.45...

Continue reading

ZenaTech’s Quantum Computing “Sky Traffic” Project Demonstrates High Accuracy in Initial Testing Leading to Expansion of Team and AI Drone Applications for Commercial and Defense

VANCOUVER, British Columbia, Feb. 19, 2025 (GLOBE NEWSWIRE) — ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) (“ZenaTech”), a technology company specializing in AI (Artificial Intelligence) drones, Drone as a Service (DaaS), enterprise SaaS and Quantum Computing solutions, announces positive results from initial testing and an update on its Quantum Computing Sky Traffic project. An initial test using the Company’s AI algorithms and quantum computing to predict weather has resulted in a high level of accuracy for the parameters tested including actual temperatures verses predicted temperatures in the test which used 2016 data. Due in part to these encouraging results, ZenaTech is now growing its internal team over the next two months. As part of the ramp up, the Company is adding additional quantum, AI and hardware...

Continue reading

Appian Announces Fourth Quarter and Full Year 2024 Financial Results

Fourth quarter cloud subscription revenue increased 19% year-over-year to $98.9 millionFull year cloud subscription revenue increased 21% year-over year to $368.0 million MCLEAN, Va., Feb. 19, 2025 (GLOBE NEWSWIRE) — Appian (Nasdaq: APPN) today announced financial results for the fourth quarter and full year ended December 31, 2024. “In 2024, Appian demonstrated its ability to grow with increasing efficiency. We specialize in creating value with AI, by deploying it in a process. While others bring work to AI, we bring AI to work,” said Matt Calkins, CEO & Founder. Fourth Quarter 2024 Financial Highlights:Revenue: Cloud subscription revenue was $98.9 million, up 19% compared to the fourth quarter of 2023. Total subscriptions revenue, which includes sales of our cloud subscriptions, on-premises term license subscriptions,...

Continue reading

Krystal Biotech Announces Fourth Quarter and Full Year 2024 Financial and Operating Results

Fourth quarter revenues increased 116% to $91.1 million versus fourth quarter of 2023 Full year revenues increased 473% to $290.5 million versus 2023 CFF TDN granted full sanctioning of KB407 Phase 1 protocol Strong balance sheet, ending the quarter with $749.6 million in cash and investments PITTSBURGH, Feb. 19, 2025 (GLOBE NEWSWIRE) — Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company, today reported financial results for the fourth quarter and full year ending December 31, 2024 and provided a business update. “Last year, our commercial and financial strength allowed us to deliver significant earnings growth, continue to build out a global footprint, and advance multiple clinical stage programs from our industry-leading HSV-1 based gene delivery platform,” said Krish S. Krishnan,...

Continue reading

Global-e Reports Fourth Quarter and Full Year 2024 Results

PETAH-TIKVA, Israel, Feb. 19, 2025 (GLOBE NEWSWIRE) — Global-e Online Ltd. (Nasdaq: GLBE) the platform powering global direct-to-consumer e-commerce, today reported financial results for the fourth quarter of 2024 and full year 2024. “2024 was yet another record-breaking year for Global-e, and it came to a great close with a fourth quarter which was our strongest quarter ever, as we continued to execute on our strategy and further solidify Global-e’s leadership position in the global e-commerce space,” said Amir Schlachet, Founder and CEO of Global-e. “In addition, we achieved two important financial milestones during the quarter. For the first time in our journey, we crossed the 20% Adjusted EBITDA Margin mark, which was the long-term target we set for ourselves at the IPO, and we reached GAAP profitability for the first time...

Continue reading

Amicus Therapeutics Announces Full-Year 2024 Financial Results and Corporate Updates

2024 Total Revenue of $528.3M, a 33% Increase Year-over-Year Projecting 2025 Total Revenue Growth of 17-24% at CER Anticipate Achieving Positive GAAP Net Income During H2 2025 Conference Call and Webcast Today at 8:30 a.m. ET PRINCETON, N.J., Feb. 19, 2025 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced financial results for the full-year ended December 31, 2024. “We closed 2024 beating expectations with exceptional revenue growth of 33 percent. With our portfolio and global rare disease capabilities, we have a clear path to deliver continued revenue growth and accelerating profitability in 2025 and the years ahead. We have firmly established Amicus as a unique biotechnology company:...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.